Tag:
EISAI
Latest Headlines
Latest Headlines
Eisai's H3 Biomedicine taps cancer genomics software for drug discovery effort
H3 Biomedicine has grabbed software for exploring cancer genomes as the Cambridge, MA, unit of Japan-based pharma Eisai hunts for targeted cancer drugs. Ann Arbor, MI-based Compendia Bioscience will
Pharma R&D company scrutinizes software assets
UK-based FAST Ltd. finds in recent research that 60 percent of companies are under-licensed and 40 percent are over-licensed with their software. It cites Eisai, which manages the functions of
